Targeted inhibition of Rev‐erb‐α/β limits ferroptosis to ameliorate folic acid‐induced acute kidney injury

Lianxia Guo,Tianpeng Zhang,Fei Wang,Xun Chen,Haiman Xu,Cui Zhou,Min Chen,Fangjun Yu,Shuai Wang,Deguang Yang,Baojian Wu

DOI: https://doi.org/10.1111/bph.15283

IF: 7.3

2020-11-23

British Journal of Pharmacology

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Purpose</h3><p>Acute kidney injury (AKI) is a common and critical illness, resulting in severe morbidity and a high mortality. There is a considerable interest in identifying novel molecular targets for management of AKI. Here, we investigated the potential role of the circadian clock components Rev‐erbα/β in regulation of ferroptosis and AKI.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Experimental Approach</h3><p>AKI model was established by treating mice with folic acid (FA). Regulatory effects of Rev‐erbα/β on AKI and ferroptosis were determined using single gene knockout (<i>Rev‐erbα</i>^{<i>‐/‐</i>} and <i>Rev‐erbβ</i>^{<i>‐/‐</i>}) mice, incomplete double knockout (icDKO, <i>Rev‐erbα</i>^<i>+/‐</i> <i>Rev‐erbβ</i>^{<i>‐/‐</i>}) mice, and cells with erastin‐induced ferroptosis. Targeted antagonism of Rev‐erbα/β to alleviate AKI and ferroptosis was assessed using the small‐molecule antagonist SR8278. Transcriptional gene regulation was investigated using luciferase reporter, mobility shift, and chromatin immunoprecipitation assays. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Key Results</h3><p>Loss of Rev‐erbα or Rev‐erbβ reduced the sensitivity of mice to FA‐induced AKI and eliminated the circadian time‐dependency in disease severity. This coincided with less extensive ferroptosis, a main cause of FA‐induced AKI. Moreover, icDKO mice were more resistant to FA‐induced AKI and ferroptosis as compared to single gene knockout mice. Supporting this, targeting Rev‐erbα/β by SR8278 attenuated ferroptosis to ameliorate FA‐induced AKI in mice. Mechanistically, Rev‐erbα/β promoted ferroptosis by repressing the transcription of <i>Slc7a11</i> and <i>HO‐1</i> (two ferroptosis‐inhibitory genes) via direct binding to a RORE cis‐element. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion and Implications</h3><p>Targeted inhibition of Rev‐erbα/β limits ferroptosis to ameliorate FA‐induced AKI in mice. The findings may have implications for improved understanding of circadian clock‐controlled ferroptosis and for formulating new strategies to treat AKI.</p></section>

pharmacology & pharmacy